Driving awareness of new Biotech firm helping develop the world’s first treatment for TUBB4a leukodystrophy.
The media results kicked off with a bang in the new year as BBC World Service aired a fantastic business programme featuring the founder of SynaptixBio. A big win for our client SynaptixBio which is aiming to develop the world’s first treatment for TUBB4a leukodystrophy.
This set in motion a phenomenal year of coverage for the client, which now includes major features on Sky News, ITV News, BBC News, and Yahoo! News.
In total, we helped SynaptixBio secure 149 articles internationally in 2022, with an estimated audience reach of 2.2 billion. The company was mentioned almost 400 times in media content – and the year isn’t quite over yet.
The results
A selection of coverage
Build awareness and credibility today
Contact our team to better understand how quality news articles in newspapers; interviews on radio and TV; and reviews and features online can take your business to the next level.